{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:22:34Z","timestamp":1783171354071,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012207"],"award-info":[{"award-number":["2024A1515012207"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2024A04J4634"],"award-info":[{"award-number":["2024A04J4634"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303738"],"award-info":[{"award-number":["82303738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072029"],"award-info":[{"award-number":["82072029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejso.2026.111853","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:40:54Z","timestamp":1777545654000},"page":"111853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative MRI features for predicting response to postoperative adjuvant anti-PD-1 therapy in hepatocellular carcinoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Xiaofang","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuifang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111853_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.111853_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.111853_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.24710","article-title":"Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008","volume":"55","author":"Altekruse","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111853_bib4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.25832","article-title":"Resection of hepatocellular cancer \u22642 cm: results from two Western centers","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2026.111853_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12072-022-10478-6","article-title":"Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy","volume":"17","author":"Chen","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejso.2026.111853_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112950","article-title":"Neoadjuvant and adjuvant systemic therapies in loco-regional treatments for hepatocellular carcinoma: are we at the dawn of a new era?","volume":"15","author":"Nevola","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111853_bib7","article-title":"Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate\/advanced hepatocellular carcinoma a multicenter propensity matching analysis","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejso.2026.111853_bib8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.111853_bib9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41591-023-02786-7","article-title":"Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.111853_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/radiol.2020192275","article-title":"Radiologic-pathologic correlation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement at gadoxetic acid-enhanced MRI: a multicenter study","volume":"296","author":"Joo","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.111853_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00261-018-1768-9","article-title":"Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis","volume":"44","author":"Ahn","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.ejso.2026.111853_bib12","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/s41598-017-02706-z","article-title":"Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging","volume":"7","author":"Hectors","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2026.111853_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000513704","article-title":"MRI features for predicting microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"10","author":"Hong","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejso.2026.111853_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nbt1306","article-title":"Decoding global gene expression programs in liver cancer by noninvasive imaging","volume":"25","author":"Segal","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ejso.2026.111853_bib15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2214\/AJR.11.7163","article-title":"Next generation radiologic-pathologic correlation in oncology: rad-path 2.0","volume":"197","author":"Kuo","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2026.111853_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","article-title":"Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma","volume":"67","author":"Lee","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111853_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/SLA.0b013e31821ad884","article-title":"Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria","volume":"254","author":"Lim","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111853_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109663","article-title":"Preoperative MR imaging for predicting early recurrence of solitary hepatocellular carcinoma without microvascular invasion","volume":"138","author":"Wei","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ejso.2026.111853_bib19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jhep.2018.01.024","article-title":"Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma","volume":"68","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111853_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/hepr.13612","article-title":"Report of the 21st nationwide Follow-up survey of primary liver cancer in Japan (2010-2011)","volume":"51","author":"Kudo","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ejso.2026.111853_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12943-018-0864-3","article-title":"Biomarkers for predicting efficacy of PD-1\/PD-L1 inhibitors","volume":"17","author":"Yi","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejso.2026.111853_bib22","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","article-title":"Progenitor-like exhausted SPRY1(+)CD8(+) T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejso.2026.111853_bib23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2022.03.039","article-title":"Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma","volume":"77","author":"Chuah","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111853_bib24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","article-title":"Biomarkers for immunotherapy of hepatocellular carcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111853_bib25","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1245\/s10434-022-11344-3","article-title":"Role of preoperational imaging traits for guiding treatment in single \u2264 5 Cm hepatocellular carcinoma","volume":"29","author":"Wei","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111853_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40364-023-00535-z","article-title":"Biomarkers and prognostic factors of PD-1\/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark Res"},{"key":"10.1016\/j.ejso.2026.111853_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000518048","article-title":"Higher enhancement intrahepatic nodules on the hepatobiliary phase of Gd-EOB-DTPA-Enhanced MRI as a poor responsive marker of Anti-PD-1\/PD-L1 monotherapy for unresectable hepatocellular carcinoma","volume":"10","author":"Aoki","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejso.2026.111853_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030827","article-title":"Evaluating the role of hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging in predicting treatment impact of lenvatinib and atezolizumab plus Bevacizumab on unresectable hepatocellular carcinoma","volume":"14","author":"Sasaki","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejso.2026.111853_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s40425-019-0766-y","article-title":"Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC","volume":"7","author":"Qayyum","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejso.2026.111853_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3348\/kjr.2015.16.3.449","article-title":"MRI features of hepatocellular carcinoma related to biologic behavior","volume":"16","author":"Cho","year":"2015","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.ejso.2026.111853_bib31","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1007\/s00330-019-06088-w","article-title":"IVIM improves preoperative assessment of microvascular invasion in HCC","volume":"29","author":"Wei","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2026.111853_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.2015150998","article-title":"Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?","volume":"279","author":"Renzulli","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2026.111853_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","article-title":"Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma","volume":"70","author":"Xu","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2026.111853_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-024-02997-x","article-title":"Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC","volume":"43","author":"de Miguel-Perez","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111853_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1754-9485.13426","article-title":"Role of radiomics in predicting immunotherapy response","volume":"66","author":"Kothari","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ejso.2026.111853_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000488540","article-title":"Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features","volume":"8","author":"Rhee","year":"2019","journal-title":"Liver Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:59:10Z","timestamp":1783169950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326004725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0748798326004725"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111853","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative MRI features for predicting response to postoperative adjuvant anti-PD-1 therapy in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111853"}}